Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Metabolic Syndrome
Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG
The latest GLP-1 drug approved for weight loss, tirzepatide, sold as Zepbound, appears to beat out semaglutide with nearly 19 percent of body weight lost, over 40 pounds (18 kg), with more like five and a half inches (14 cm) off the waist
Koeth RA, Levison BS, Culley MK, et al
Umbilical Cord MSCs and Bone Regeneration Umbilical cord MSCs differentiate osteogenically when GHK combines with alginate hydrogel, showing 10-fold Runx2 mRNA increases before chemical induction through ILK (integrin-linked kinase) activation
Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis
US$ 27.44
US$ 28.26
US$ 27.28
